Precision Appoints Michael Amoroso as Their New CEO
On Monday, September 27, Precision BioSciences announced (press release) the appointment of Michael Amoroso as the company’s President, Chief Executive Officer (CEO), and member of the Board of Directors, all effective October 15, 2021. Below, Celltelligence provides insights on how Amoroso could lead Precision through their next phase of growth.
About The Author
The Celltelligence team has combined experience in oncology, including cell therapy, CAR-T, immunology, microbiology, biochemistry, and other various fields in life sciences. Our team members include PhDs, industry veterans, and analysts tuned to The Street – all of whom help to create a more actionable service of delivering cell therapy intelligence.
If you receive our email blasts, you already have an account. Log in now
You’ll be able to access the full article from your Celltelligence Library after signing up.